0001104659-22-000976.txt : 20220104 0001104659-22-000976.hdr.sgml : 20220104 20220104170829 ACCESSION NUMBER: 0001104659-22-000976 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carroll David Francis CENTRAL INDEX KEY: 0001703623 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 22507266 MAIL ADDRESS: STREET 1: ONE UNIVERSITY SQUARE DRIVE, SUITE 280 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PENN PLAZA STREET 2: SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: 5 PENN PLAZA STREET 2: SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 tm221330-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-12-31 0 0001410939 IVERIC bio, Inc. ISEE 0001703623 Carroll David Francis C/O IVERIC BIO, INC. 5 PENN PLAZA, SUITE 2372 NEW YORK NY 10001 0 1 0 0 SVP, CFO and Treasurer Common Stock 2021-12-31 4 M 0 32500 A 81323 D Common Stock 2022-01-03 4 S 0 15819 16.3923 D 65504 D Restricted Stock Units 2021-12-31 4 M 0 32500 0 D Common Stock 32500 0 D Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units. Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 31, 2021. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.77 to $16.77 on January 3, 2022 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. On December 9, 2019, the Reporting Person was granted 65,000 restricted stock units, which vest with respect to 50% of the shares subject to the award on December 31, 2020 and with respect to the remaining 50% of the shares subject to the award on December 31, 2021, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan. /s/ Todd Anderman, as Attorney-in-Fact for David F. Carroll 2022-01-04